The Endocrine Efficacy of Either Recombinant Luteinizing Hormone (r-LH) or Low Dose Recombinant Human Chorionic Gonadotropin (r-hCG) Supplementation for Recombinant Follicle Stimulating Hormone (r-FSH) Stimulation in Normogonadotrophic Women Undergoing in Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Therapy Following a Long-term Gonadotropin Releasing Hormone (GnRH) Agonist Down Regulation Protocol

NCT01339299 Phase 4 COMPLETED Results posted

The study is a prospective, randomised, controlled, and non-blinded multi-center pilot study to evaluate endocrine efficacy of recombinant luteinizing hormone versus recombinant human chorionic gonadotropin administered during controlled ovarian stimulation for IVF/ICSI in normogonadotrophic women.

Details

Lead sponsor	Regionshospitalet Viborg, Skive
Phase	Phase 4
Status	COMPLETED
Enrolment	100
Start date	2009-10
Completion	2012-07

Conditions

• Controlled Ovarian Stimulation
• Infertility

Interventions

• recombinant luteinizing hormone (r-LH)
• recombinant human chorionic gonadotropin (r-hCG)

Primary outcomes

• The Oestradiol Concentration on the Day of Ovulation Induction — treatment day 10 to 14

Countries

Denmark